Date: 4 December 2025
Ticker: Wesfarmers Limited (ASX:WES)
Wesfarmers shares are hovering around A$82 on Thursday, 4 December 2025, as investors absorb a A$1.50 per share capital management distribution, a fresh AI partnership with OpenAI, and a mixed set of broker forecasts that lean cautious despite robust FY25 earnings.
Below is a detailed rundown of what’s happening with Wesfarmers stock today – and how current news, forecasts and analysis are framing the outlook.
Wesfarmers share price on 4 December 2025
As at the close of trade on Wednesday 3 December, Wesfarmers Limited (ASX:WES) finished at A$81.72, up marginally on the day. Technical data show the stock has traded in a 52‑week range of about A$67.70 to A$95.18, leaving it mid‑range heading into today’s session.
Key snapshot:
- Last close: A$81.72 (3 December 2025)
- Recent intraday range: roughly A$81 – A$82.6 on Wednesday
- 52‑week range: ~A$67.7 – A$95.2
- Market cap: around A$93 billion
Rask Media recently noted the Wesfarmers share price is up about 15–16% in 2025 year‑to‑date, even after a sharp ~15% pullback in October, a slump highlighted again this morning in a new Motley Fool Australia piece titled “Is it time to sell your Wesfarmers shares?”. Rask Media+2The Motley Fool Australia+2
In other words: the stock has already run reasonably hard this year, corrected sharply in October, and is now consolidating just above the A$80 mark.
Big cash day: A$1.50 per share capital management distribution hits accounts
4 December 2025 is payout day for Wesfarmers’ much‑discussed A$1.50 per share capital management distribution. That total is split into:
- A$1.10 per share return of capital (the “Capital Component”)
- A$0.40 per share fully‑franked special dividend (the “Dividend Component”)
Some key details from Wesfarmers’ own capital management documentation:
- The board announced the A$1.703 billion distribution alongside FY25 results, funded from asset sales such as the remaining stake in Coles, the sale of Coregas, and divestments in LPG/LNG distribution.
- Shareholders approved the return of capital at the AGM on 30 October 2025, with the structure subject to an Australian Tax Office (ATO) ruling (mainly about tax classification, not whether the cash is paid).
- Record date: 6 November 2025, 4:00pm Perth time.
- Payment date: today, 4 December 2025, for both the capital return and the special dividend.
- No share consolidation: the number of Wesfarmers shares on issue does not change – the capital base is reduced, but ownership percentages stay the same.
For Dividend Investment Plan (DIP/DRP) participants, the special dividend of A$0.40 is being reinvested into new shares at a price of A$81.0055, calculated from the 15‑day volume‑weighted average price leading up to the record date. The A$1.10 capital component does not participate in the DRP.
What does this mean in yield terms?
From FY25 results and the capital management initiative:
- Ordinary FY25 dividends: A$2.06 per share (95c interim + 111c final).
- Special dividend: A$0.40 per share.
- Capital return: A$1.10 per share.
On a share price around A$82:
- Trailing ordinary+special dividend yield: ~3% (2.46 ÷ 82).
- Total 2025 cash returned (including capital return): A$3.56 per share, or roughly 4.3–4.4% of the current share price.
Importantly, Wesfarmers itself stresses that this A$1.50 distribution is explicitly funded by past asset sales and is non‑recurring – investors shouldn’t assume a similar cheque every few years.
FY25 results: resilient retail, strong cash flow
Wesfarmers’ FY25 numbers, released in late August, help explain why the board felt comfortable sending A$1.7 billion back to shareholders. The official full‑year presentation shows:
- Revenue: A$45.7 billion, up 3.4% on FY24.
- EBIT (excl. significant items): A$4.19 billion, up 4.9%.
- NPAT (excl. significant items): A$2.65 billion, up 3.8%.
- Reported NPAT: A$2.93 billion, up 14.4%, helped by gains on asset sales.
- Free cash flow: A$3.45 billion, up 6.9%.
- Return on equity (ex‑sig): about 31%, which is elite territory for a diversified conglomerate.
Divisionally, the big retail engines kept doing the heavy lifting:
- Bunnings: revenue A$19.56b, up 3.3%, with earnings up around 4%, supported by ongoing DIY and trade demand.
- Kmart Group (Kmart/Target): revenue A$11.34b, up 3.4%, earnings up 9%, benefiting from productivity initiatives, system integration and strong value positioning.
- Officeworks: modest earnings growth but facing competitive pressure and some one‑off costs.
- WesCEF (chemicals, energy & fertilisers): revenue up nearly 8%, though earnings were lower due to weaker global commodity prices.
- Health: revenue up around 5–6%, with strong growth in the consumer brands (notably Priceline and related health and beauty businesses).
In comments reported by Reuters, management noted that consumer demand is showing early signs of recovery as inflation and interest rates ease, while acknowledging ongoing macro and geopolitical risks.
The combination of high returns on capital, disciplined cost control, and strong cash generation is exactly what gives Wesfarmers the firepower to both fund growth projects (like lithium and health) and execute one‑off capital returns like the one landing today.
New AI deal: Wesfarmers partners with OpenAI
One of the most noteworthy new developments heading into December is Wesfarmers’ decision to go deeper into AI, via a formal partnership with OpenAI, the creator of ChatGPT.
In a media release dated 28 November 2025, Wesfarmers announced it has:
- Entered a partnership with OpenAI to roll out ChatGPT Enterprise across the Group.
- Committed to customised AI training programs for staff in its key businesses, including Bunnings, Kmart Group, Officeworks and Health.
- Framed the initiative as a way to boost team productivity and improve customer experience both online and in‑store.
Tech trade press has linked this deal to broader AI experiments within the group, including Kmart Group’s use of AI to streamline finance operations and invoice processing, and Wesfarmers’ long‑running OneDigital data and analytics investments.
For shareholders, this doesn’t translate into immediate earnings upgrades, but it does underscore two things:
- Wesfarmers wants to protect its cost advantages by squeezing more productivity out of large retail networks.
- The group is positioning itself as a data‑rich, AI‑enabled retailer, not just a traditional bricks‑and‑mortar conglomerate.
If AI‑enabled efficiencies and improved customer experiences show up in margins over the next few years, they’ll help justify today’s relatively full valuation.
Governance update: Non‑Executive Director Equity Plan
On 3 December 2025, Wesfarmers lodged an ASX announcement introducing a Non‑Executive Director Equity Plan (NED Plan). It’s not price‑sensitive, but it is relevant for governance‑minded investors.
Key features of the plan:
- Non‑executive directors can sacrifice between 20% and 100% of their pre‑tax fees into rights that convert into Wesfarmers shares.
- Rights vest in two tranches each year (after half‑year and full‑year results), and the resulting shares are subject to disposal restrictions of 3–15 years chosen by the director.
- Shares acquired under the plan carry full dividends and voting rights, but cannot be traded until the restriction period ends, the director leaves the board, or a change‑of‑control event occurs.
The objective, as stated by the company, is to further align director and shareholder interests and help new directors reach their minimum shareholding guideline.
It’s a small detail in valuation terms, but it reinforces Wesfarmers’ long‑standing focus on alignment, long‑term incentives and capital discipline.
What are analysts saying about Wesfarmers now?
Here’s where things get interesting: the stock is high quality, the balance sheet is strong – and yet the consensus rating is cautious.
Broker consensus and price targets
According to Investing.com’s consensus data (updated within the last three months):
- Overall consensus rating:“Sell”
- Analyst mix (13 analysts):
- 1 x Buy
- 6 x Hold
- 6 x Sell
- Average 12‑month price target:A$80.82
- Target range: A$58 (low) to A$100 (high)
- Implied 12‑month downside from ~A$81.7: roughly –1% on average.
Recent rating actions (mostly on the ADR, WFAFF) show:
- J.P. Morgan: Sell
- Citi: Sell
- Ord Minnett, Macquarie, Morgan Stanley, UBS: generally Hold with targets not far above current levels.
In other words, most brokers see limited upside from here over 12 months – not a disaster, but not a screaming bargain either.
Dividend forecasts out to 2030
Dividend‑focused research and broker models quoted by Motley Fool Australia and other outlets suggest:
- UBS expects Wesfarmers’ ordinary dividend per share (excluding the current special) to rise from around A$2.06 in FY25 to roughly A$2.08 in FY26, A$2.30 in FY27, and A$2.59 by FY28, with further growth out toward FY30.
- At today’s share price, those projections translate to a forward ordinary yield in the 3½–4% range, assuming the company hits those dividend forecasts.
A recent dividend‑centric piece characterises Wesfarmers as an “ASX dividend stalwart”, emphasising the combination of reliable, fully‑franked dividends and a strong balance sheet. The Motley Fool Australia+1
Valuation metrics
Independent data providers and screeners currently show:
- Trailing P/E: ~31–32x
- Forward P/E (based on FY26 estimates): also low‑30s.
- Price‑to‑sales: ~2.0x.
- 2025 cash yield (ordinary + special + capital return): ~4.3% on today’s price.
Most quantitative and qualitative summaries (including a detailed TS2.tech breakdown published on 2 December) frame Wesfarmers as:
A high‑quality compounding business priced roughly at fair value, with a generous but partly one‑off income kicker in 2025, rather than a classic “deep value” opportunity.
Technical and short‑term trading outlook
On the purely technical side, StockInvest.us upgraded Wesfarmers from Sell to Hold/Accumulate on 3 December 2025, but its model still expects a possible price pullback over the next few months:
- Recent price action: up in 7 of the last 10 sessions, with ~2.2% gain over two weeks.
- Short‑term trend: “wide and falling” – their model projects a –14.6% move over three months, with a 90% probability range of roughly A$66.8–A$75.3.
- Next‑day trading expectation (for Thursday 4 December): open near A$81.77 and potentially trade between A$80.95–A$82.49, based on recent volatility.
They classify the stock as a “Hold/Accumulate” technically – acknowledging positive short‑term signals (MACD, volume, pivot bottom) but a still‑negative longer‑term trend.
As always with quant models, those ranges are probabilistic, not promises, but they help explain why some traders see an elevated risk of another dip if sentiment turns.
Bull vs bear: how the market is framing Wesfarmers in December 2025
Pulling together company reports, broker notes and recent analysis, the debate looks roughly like this.
The bull case
- Dominant retail franchises: Bunnings and Kmart/Target hold leading positions in value‑driven home improvement and discount general merchandise – categories that tend to hold up reasonably well in tougher times.
- Outstanding returns on capital: ROE north of 30% (ex‑significant items) is rare for a conglomerate of this size.
- Strong balance sheet and cash generation: enough to fund growth, sustain fully‑franked dividends and still return A$1.7b in surplus capital.
- Strategic growth options:
- Lithium joint venture (with SQM) and Kwinana hydroxide refinery for long‑term exposure to EV battery demand.
- Expanding Wesfarmers Health platform (Priceline and associated businesses).
- OneDigital and the new OpenAI partnership, which could unlock structural efficiency gains.
- Income appeal: a solid base of fully‑franked dividends plus the 2025 one‑off distribution looks attractive relative to term deposits for many local investors.
The cautious / bear case
- Valuation stretch: At ~A$82 and a P/E in the low‑30s, Wesfarmers trades at a premium multiple to many other ASX retailers and industrials, while consensus forecasts show limited near‑term upside.
- Macro sensitivity: Despite its “value” positioning, Wesfarmers still depends heavily on Australian consumer and housing demand – both vulnerable to persistent cost‑of‑living pressures.
- Divisional pressure points: Officeworks and Industrial & Safety face tougher trading, while the Health and lithium businesses require ongoing heavy investment before contributing meaningfully to group earnings.
- Non‑recurring kicker: The A$1.50 distribution is one‑off and funded by past divestments; relying on it to justify paying a premium multiple is risky.
- Technical setup: After a strong multi‑year run and a recent October correction, quantitative models and some brokers warn of a possible further consolidation or pullback if earnings or macro data disappoint.
This tension – high quality vs full valuation – is exactly why today’s commentary ranges from “great long‑term compounder” to “time to trim or sell”.
So what does 4 December 2025 really change?
From a fundamentals perspective, today crystallises value rather than creating it:
- The A$1.50 per share capital management distribution is cash that has effectively already been recognised in past asset sales and, to a large extent, priced in when the shares went ex‑distribution in early November.
- The OpenAI partnership indicates Wesfarmers is serious about staying at the front of the pack on AI and digital, but this is an enabler rather than an immediate earnings lever.
- The Non‑Executive Director Equity Plan modestly improves governance alignment but doesn’t move the valuation dial on its own.
For income‑oriented, long‑term holders, today is essentially a liquidity event: a chunk of capital is returned; you can reinvest it (in WES via the DRP or elsewhere), use it for diversification, or simply enjoy the cash while continuing to own a high‑quality, diversified conglomerate.
For valuation‑sensitive or more tactical investors, the picture is subtler:
- Consensus broker targets cluster near the current price.
- Technical models flag the risk of a further pullback if sentiment sours.
- At the same time, Wesfarmers’ track record of capital allocation, cash generation and portfolio renewal remains impressive, and few question the quality of the underlying franchises.
Whether Wesfarmers is a buy, hold or sell at today’s levels ultimately depends on:
- Your view of Australian consumer resilience over the next few years;
- How much you value dividend stability and franking credits; and
- Your tolerance for paying a premium multiple for what many still regard as one of the ASX’s highest‑quality conglomerates.
